enGene finalizes employment agreements with CEO, COO, CSO, CTO; salaries $450k-$590k

enGene Therapeutics Inc.

CEO Jason Hanson: $590k base, 55% annual bonus target, 12-month severance non-CIC, 18-month CIC.
COO Alex Nichols: $475k base, 40% bonus target, 12-month severance non-CIC, 12-month CIC.
CSO James Sullivan: $485k base, 40% bonus target, 12-month severance non-CIC, 12-month CIC.
CTO Anthony Cheung: $450k base, 40% bonus target, 18-month severance (non-CIC and CIC).
All agreements effective Nov 1, 2023; cover restrictive covenants, equity acceleration, and COBRA.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.